Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which can help slow or stop the growth of cancer cells.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed for early-stage breast cancer after surgery and for advanced breast cancer. The medication is designed to lower estrogen levels, which can help inhibit the growth of cancer cells that rely on estrogen to proliferate.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users may also experience nausea, headache, or dizziness. These effects can vary in severity and duration, and not everyone will experience them.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be recommended to assess bone health and liver function.

Femara may interact with certain medications, including estrogen-containing therapies, tamoxifen, and some antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.